Haleon PLC Sponsored ADR $HLN Shares Bought by Sculptor Capital LP

Key Points

• Sculptor Capital LP has increased its stake in Haleon PLC by 22.1%, now holding approximately 10.8 million shares, which represents around 2.1% of its investment portfolio.
• Haleon recently declared a semi-annual dividend of $0.0555 per share, up from the previous $0.05, with a yield of 190.0%.
• Wall Street analysts have given Haleon a consensus rating of "Moderate Buy" with an average target price of $12.33, reflecting a mix of upgrades and downgrades from various firms.

Sculptor Capital LP raised its holdings in shares of Haleon PLC Sponsored ADR (NYSE:HLN - Free Report) by 22.1% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,849,868 shares of the company's stock after acquiring an additional 1,962,770 shares during the quarter. Haleon makes up 2.1% of Sculptor Capital LP's investment portfolio, making the stock its 6th largest holding. Sculptor Capital LP owned 0.24% of Haleon worth $111,645,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of HLN. Bartlett & CO. Wealth Management LLC grew its stake in Haleon by 135.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company's stock valued at $27,000 after acquiring an additional 1,491 shares in the last quarter. Opal Wealth Advisors LLC purchased a new position in Haleon during the 1st quarter valued at about $29,000. Deutsche Bank AG grew its stake in Haleon by 267.8% during the 1st quarter. Deutsche Bank AG now owns 3,126 shares of the company's stock valued at $32,000 after acquiring an additional 2,276 shares in the last quarter. Continuum Advisory LLC grew its stake in Haleon by 152.4% during the 1st quarter. Continuum Advisory LLC now owns 4,753 shares of the company's stock valued at $49,000 after acquiring an additional 2,870 shares in the last quarter. Finally, Alpine Bank Wealth Management purchased a new position in Haleon during the 1st quarter valued at about $56,000. Hedge funds and other institutional investors own 6.67% of the company's stock.

Wall Street Analyst Weigh In

HLN has been the topic of several research analyst reports. BNP Paribas raised Haleon to a "strong-buy" rating in a research note on Tuesday, May 27th. Morgan Stanley upgraded Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price target for the company in a report on Friday, May 9th. Wall Street Zen lowered Haleon from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. BNP Paribas Exane upgraded Haleon from a "neutral" rating to an "outperform" rating and set a $13.40 price target for the company in a report on Tuesday, May 27th. Finally, Barclays reiterated an "overweight" rating on shares of Haleon in a report on Tuesday, May 6th. Two investment analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $12.33.

Haleon Stock Performance

HLN traded down $0.04 on Tuesday, hitting $9.77. The company had a trading volume of 10,851,949 shares, compared to its average volume of 7,797,468. The company's fifty day moving average price is $9.83 and its 200 day moving average price is $10.22. Haleon PLC Sponsored ADR has a 1-year low of $8.86 and a 1-year high of $11.42. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.87 and a quick ratio of 0.63. The stock has a market cap of $43.78 billion, a price-to-earnings ratio of 25.13, a price-to-earnings-growth ratio of 2.89 and a beta of 0.24.

Haleon Increases Dividend

The business also recently announced a semi-annual dividend, which will be paid on Thursday, September 18th. Investors of record on Friday, August 15th will be issued a $0.0555 dividend. This is an increase from Haleon's previous semi-annual dividend of $0.05. The ex-dividend date is Friday, August 15th. This represents a yield of 190.0%. Haleon's dividend payout ratio is presently 28.21%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.